Related Experiment Video
Updated: Jul 3, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases
Abdul Mannan Khan Minhas1, Khawaja M Talha1, Dmitry Abramov2
1Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Insights
Racial disparities in cardiovascular disease (CVD) are widespread. Non-Hispanic Black adults face significant disadvantages in CVD prevalence, risk factors, mortality, and treatment compared to Non-Hispanic White adults.
Area of Science:
- Public Health
- Cardiovascular Medicine
- Health Disparities Research
Background:
- Existing studies analyze cardiovascular disease (CVD) disparities using various databases, but a unified analysis is lacking.
- This study addresses the need for a comprehensive examination of racial and ethnic disparities in CVD within the US.
Purpose of the Study:
- To examine racial and ethnic disparities in CVD prevalence, risk factors, morbidity, and mortality.
- To assess disparities in cardiovascular trainee representation across racial and ethnic groups.
Main Methods:
- Utilized multiple large-scale datasets: National Health and Nutrition Examination Survey, National Ambulatory Medical Care Survey, National Inpatient Sample, CDC WONDER, UNOS, and ACGME.
- Evaluated disparities among Non-Hispanic (NH) White, NH Black, and Hispanic populations.
Main Results:
- NH Black adults exhibited higher prevalence of most CVDs and risk factors, except dyslipidemia and ischemic heart disease (IHD).
- Underutilization of statins for IHD in NH Black and Hispanic patients was observed. Hospitalizations for heart failure (HF) and stroke were higher in NH Black patients.
- NH Black individuals experienced the highest mortality rates for all-cause, CVD, HF, acute myocardial infarction, IHD, diabetes mellitus, hypertension, and cerebrovascular disease. Representation of NH Black and Hispanic trainees in CVD fellowship programs was disproportionately low.
Conclusions:
- Racial disparities are pervasive across the entire spectrum of cardiovascular diseases.
- Non-Hispanic Black adults are at a significant disadvantage compared to Non-Hispanic White adults regarding most CVD outcomes and representation in training.
Background:
There are several studies that have analyzed disparities in cardiovascular disease (CVD) health using a variety of different administrative databases; however, a unified analysis of major databases does not exist. In this analysis of multiple publicly available datasets, we sought to examine racial and ethnic disparities in different aspects of CVD, CVD-related risk factors, CVD-related morbidity and mortality, and CVD trainee representation in the US.
Methods:
We used National Health and Nutrition Examination Survey, National Ambulatory Medical Care Survey, National Inpatient Sample, Centers for Disease Control and Prevention Wide-Ranging OnLine Data for Epidemiologic Research, United Network for Organ Sharing, and American Commission for Graduate Medical Education data to evaluate CVD-related disparities among Non-Hispanic (NH) White, NH Black and Hispanic populations.
Results:
The prevalence of most CVDs and associated risk factors was higher in NH Black adults compared to NH White adults, except for dyslipidemia and ischemic heart disease (IHD). Statins were underutilized in IHD in NH Black and Hispanic patients. Hospitalizations for HF and stroke were higher among Black patients compared to White patients. All-cause, CVD, heart failure, acute myocardial infarction, IHD, diabetes mellitus, hypertension and cerebrovascular disease related mortality was highest in NH Black or African American individuals. The number of NH Black and Hispanic trainees in adult general CVD fellowship programs was disproportionately lower than NH White trainees.
Conclusion:
Racial disparities are pervasive across the spectrum of CVDs with NH Black adults at a significant disadvantage compared to NH White adults for most CVDs.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Statistical Methods for Analyzing Epidemiological Data
Comparing the Survival Analysis of Two or More Groups